niacin and sincalide
niacin has been researched along with sincalide in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Akiyama, T; Hirohata, Y; Otsuki, M; Shirohara, H; Tachibana, I; Yamamoto, M | 1 |
| Kanagawa, K; Otsuki, M; Tachibana, I; Yamamoto, Y | 1 |
Reviews
1 review(s) available for niacin and sincalide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
2 other study(ies) available for niacin and sincalide
| Article | Year |
|---|---|
Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist.
Topics: Amylases; Animals; Benzodiazepinones; Binding, Competitive; Cerebral Cortex; Cysteine; Devazepide; In Vitro Techniques; Intracellular Membranes; Male; Niacin; Pancreas; Proglumide; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Sincalide | 1996 |
Pharmacological profile of a new serine derivative cholecystokinin receptor antagonist TP-680 on pancreatic, biliary and gastric function.
Topics: Animals; Biliary Tract; Bombesin; Cysteine; Female; Gastric Acid; Gastric Emptying; Male; Mice; Niacin; Pancreas; Pentagastrin; Rats; Rats, Wistar; Receptors, Cholecystokinin; Secretin; Sincalide; Stomach | 1996 |